Liraglutide 3.0 mg daily significantly cut weight, waist, and HbA1c in people with HIV and obesity
Efficacy and acceptability of liraglutide for obesity in people with HIV: results of an open-label clinical trial in South Africa.
Abstract
Liraglutide 3.0 mg daily reduced weight by -2.9%, waist circumference by -5.6 cm, and HbA1c by -0.3% in obese PWH.